164 related articles for article (PubMed ID: 37852567)
21. Cardiac Amyloidosis Treatment.
Stern LK; Patel J
Methodist Debakey Cardiovasc J; 2022; 18(2):59-72. PubMed ID: 35414852
[TBL] [Abstract][Full Text] [Related]
22. Extracellular Volume Detects Amyloidotic Cardiomyopathy and Correlates With Neurological Impairment in Transthyretin-familial Amyloidosis.
Gallego-Delgado M; González-López E; Muñoz-Beamud F; Buades J; Galán L; Muñoz-Blanco JL; Sánchez-González J; Ibáñez B; Mirelis JG; García-Pavía P
Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):923-930. PubMed ID: 27291669
[TBL] [Abstract][Full Text] [Related]
23. Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
Satoskar AA; Efebera Y; Hasan A; Brodsky S; Nadasdy G; Dogan A; Nadasdy T
Am J Surg Pathol; 2011 Nov; 35(11):1685-90. PubMed ID: 21945954
[TBL] [Abstract][Full Text] [Related]
24. Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review.
Papathanasiou M; Carpinteiro A; Kersting D; Jakstaite AM; Hagenacker T; Schlosser TW; Rischpler C; Rassaf T; Luedike P
Mol Genet Genomic Med; 2021 Dec; 9(12):e1581. PubMed ID: 33345470
[TBL] [Abstract][Full Text] [Related]
25. Cardiac amyloidosis-interdisciplinary approach to diagnosis and therapy.
Hänselmann A; Berliner D; Bauersachs J; Bavendiek U
Herz; 2022 Aug; 47(4):324-331. PubMed ID: 35674775
[TBL] [Abstract][Full Text] [Related]
26. When to Suspect and How to Approach a Diagnosis of Amyloidosis.
Law S; Gillmore JD
Am J Med; 2022 Apr; 135 Suppl 1():S2-S8. PubMed ID: 35081377
[TBL] [Abstract][Full Text] [Related]
27. Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shock.
Damy T; Plante-Bordeneuve V; Dogan A
Arch Cardiovasc Dis; 2014 Dec; 107(12):706-8. PubMed ID: 24070596
[No Abstract] [Full Text] [Related]
28. Reverse cardiac remodelling and dysfunction in A97S transthyretin cardiac amyloidosis after tafamidis treatment.
Wu YA; Tsai CH; Su MY; Chao CC; Cheng MF; Shun CT; Hsieh ST; Lin YH
ESC Heart Fail; 2022 Dec; 9(6):4335-4339. PubMed ID: 36128649
[TBL] [Abstract][Full Text] [Related]
29. Transthyretin Amyloid Cardiomyopathy-Current and Future Therapies.
Yadav JD; Othee H; Chan KA; Man DC; Belliveau PP; Towle J
Ann Pharmacother; 2021 Dec; 55(12):1502-1514. PubMed ID: 33685242
[TBL] [Abstract][Full Text] [Related]
30. Strong positive light chain immunostaining in a patient with transthyretin amyloidosis.
Chen J; Chen H; Zhou L; Liu D; Du F; Xiang H
Hematology; 2023 Dec; 28(1):2244315. PubMed ID: 37551718
[TBL] [Abstract][Full Text] [Related]
31. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
[TBL] [Abstract][Full Text] [Related]
32. Amyloid cardiomyopathy.
Kristen AV
Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
[TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and treatment of cardiac transthyretin amyloidosis. Innovative therapy with tafamidis.].
Legrand D; Nyssen A; Jackers L; Brogneaux C; Pirotte I; Grayet D; Lacremans D; Magnée M
Rev Med Liege; 2022 Jan; 77(1):63-68. PubMed ID: 35029343
[TBL] [Abstract][Full Text] [Related]
34. A Reliable Baton Passing From Orthopedic Surgeon to Cardiologist - Cardiac Screening in Patients With Carpal Tunnel Syndrome for Early Diagnosis of Transthyretin Amyloid Cardiomyopathy.
Ikura H; Kitakata H; Endo J
Circ J; 2023 Jul; 87(8):1056-1057. PubMed ID: 37438146
[No Abstract] [Full Text] [Related]
35. Acute cardiac failure secondary to senile systemic amyloidosis.
Bodard Q; Roca F; Dilly B; Laurent D; Chassagne P
Age Ageing; 2016 Nov; 45(6):908-909. PubMed ID: 27103598
[TBL] [Abstract][Full Text] [Related]
36. [Suspected cardiac amyloidosis - diagnostic steps for evaluation].
Feldmann K; Hamm CW; Aßmus B
Dtsch Med Wochenschr; 2020 Aug; 145(16):1162-1168. PubMed ID: 32791553
[TBL] [Abstract][Full Text] [Related]
37. Trajectory of left ventricular geometry and diastolic dysfunction in hereditary transthyretin cardiac amyloidosis.
Akatsuka T; Fujimoto N; Ishiyama M; Nakamori S; Imanaka-Yoshida K; Dohi K
ESC Heart Fail; 2021 Aug; 8(4):3422-3426. PubMed ID: 34145794
[TBL] [Abstract][Full Text] [Related]
38. [State-of-the-art review on the non-invasive diagnosis approaches of patients with transthyretin cardiac amyloidosis].
He S; Tian Z; Zhang SY
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):276-279. PubMed ID: 32370477
[TBL] [Abstract][Full Text] [Related]
39. [Ten questions about transthyretin amyloidosis].
Giovannetti A; Accietto A; Massa P; Leone O; Guaraldi P; Saturi G; Caponetti AG; Sguazzotti M; Ponziani A; Gagliardi C; Galiè N; Cortelli P; Longhi S; Biagini E
G Ital Cardiol (Rome); 2022 Sep; 23(9):676-685. PubMed ID: 36039718
[TBL] [Abstract][Full Text] [Related]
40. Neuromuscular Complications of Systemic Amyloidosis.
Namiranian D; Geisler S
Am J Med; 2022 Apr; 135 Suppl 1():S13-S19. PubMed ID: 35104443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]